Specialized Emergency Care for Frailty
Trial Summary
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Geriatric Emergency Department Innovations (GEDI) program?
Is the Geriatric Emergency Department Intervention (GEDI) safe for humans?
How is the Geriatric Emergency Department Innovations (GEDI) treatment different from other treatments for frailty?
What is the purpose of this trial?
This study evaluates the Geriatric Emergency Department Innovations (GEDI) program at Northwestern Memorial Hospital to care for older adults in the emergency department. Half of the patients will be cared for by a standard ED team plus the GEDI team, while half of the patients will receive usual ED care.
Research Team
Scott M Dresden, MD, MS
Principal Investigator
Northwestern University Department of Emergency Medicine
Eligibility Criteria
This trial is for older adults aged 65 or above who are living independently or with others, can provide informed consent, and have a Clinical Frailty Scale score of at least 4. It's not for those in critical condition, non-urgent cases, enrolled in another study, unable to follow-up or complete assessments in English, COVID-19 positive patients, prisoners, psychiatric holds or if they've had certain consultations outside the trial.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive care in the emergency department with or without the GEDI program
Follow-up
Participants are monitored for health outcomes and quality of life measures
Treatment Details
Interventions
- Geriatric Emergency Department Innovations (GEDI) program
Geriatric Emergency Department Innovations (GEDI) program is already approved in United States for the following indications:
- Emergency department care for older adults
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor